ResearchSafe

Is PE 22-28 the real deal for mood or just hype?

Posted by sasha_b in Research & News - 2 points, 0 comments.

I have been reading a lot about PE 22-28 lately. It is a synthetic peptide derived from spadin that is meant to block the TREK-1 potassium channel. The research suggests it could potentially work as a fast acting antidepressant by increasing neurogenesis and synaptogenesis. That sounds brilliant if it actually works for humans, especially compared to the weeks of waiting you get with standard SSRIs.

To be honest, I am a bit skeptical about how quickly these preclinical results translate to real world results. I have seen so many compounds look spot on in animal models only to fall flat when they hit human trials. It is still very much in the research phase and we do not really know the human safety profile yet. I am keen to see if anyone has found any solid data on its efficacy for neuroplasticity specifically.

Does anyone else think the focus on TREK-1 inhibition is the right direction for mood research, or are we just chasing the next shiny thing? I reckon we should wait for more human-centric data before getting too excited. 🔬

Community discussion - research and educational context only. Not medical advice.